Home » Stocks » NVRO

Nevro Corp. (NVRO)

Stock Price: $171.03 USD 2.06 (1.22%)
Updated November 27, 1:00 PM EST - Market closed

Stock Price Chart

Key Info

Market Cap 5.89B
Revenue (ttm) 366.69M
Net Income (ttm) -89.68M
Shares Out 34.43M
EPS (ttm) -2.73
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day November 27
Last Price $171.03
Previous Close $168.97
Change ($) 2.06
Change (%) 1.22%
Day's Open 168.60
Day's Range 167.55 - 171.44
Day's Volume 76,808
52-Week Range 65.05 - 175.71

More Stats

Market Cap 5.89B
Enterprise Value 5.64B
Earnings Date (est) Feb 25, 2021
Ex-Dividend Date n/a
Shares Outstanding 34.43M
Float 33.07M
EPS (basic) -2.72
EPS (diluted) -2.73
FCF / Share -0.84
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 2.57M
Short Ratio 8.24
Short % of Float 7.76%
Beta 1.03
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 16.06
PB Ratio 15.53
Revenue 366.69M
Operating Income -73.66M
Net Income -89.68M
Free Cash Flow -28.96M
Net Cash 250.05M
Net Cash / Share 7.26
Gross Margin 73.18%
Operating Margin -20.09%
Profit Margin -24.50%
FCF Margin -7.90%
ROA -7.35%
ROE -31.04%
ROIC -12.40%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Forecasts

Analyst Ratings (15)

Buy 11
Overweight 1
Hold 3
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

(2.08% upside)
Current: $171.03
Target: 174.58
*Average 12-month price target from 12 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Revenue Growth0.77%18.56%42.96%228.28%113.69%38.61%29.48%-
Gross Profit26827322815341.4921.3014.0310.62
Operating Income-96.48-41.74-29.58-23.08-62.37-28.31-25.15-19.13
Net Income-104-49.21-36.66-31.78-67.43-30.68-26.01-18.97
Shares Outstanding30.8030.0529.4228.4926.584.440.880.49
Earnings Per Share-3.37-1.64-1.25-1.12-2.54-6.94-29.84-38.59
Operating Cash Flow-50.23-5.71-14.27-58.50-100-31.15-21.10-22.47
Capital Expenditures-3.47-8.22-4.33-3.37-5.01-0.63-0.06-0.03
Free Cash Flow-53.70-13.93-18.60-61.87-105-31.77-21.15-22.50
Cash & Equivalents23926527027719517756.8356.83
Total Debt18115214513819.7419.51--
Net Cash / Debt58.0111312513917515856.8356.83
Book Value216245249249235172-85.79-85.79
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Nevro Corp.
Country United States
Employees 853
CEO D. Keith Grossman

Stock Information

Ticker Symbol NVRO
Stock Exchange New York Stock Exchange
Sector Healthcare
Industry Medical Devices
Unique Identifier NYSE: NVRO
IPO Date November 6, 2014


Nevro, a medical device company, provides products for the patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain. It also offers Senza II system and Senza Omnia system products for chronic pain. The company's solution for chronic pain also includes HF10 Therapy, which delivers neuromodulation solutions for treating chronic pain based on available clinical evidence. Nevro Corp. sells its products through its direct sales force, and a network of sales agents and independent distributors. The company was founded in 2006 and is headquartered in Redwood City, California.